Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve (OTCQX: TCNNF) reported Q1 2026 revenue of $287 million with a 59% gross margin, GAAP net income attributable to common shareholders of $2 million, and adjusted EBITDA of $100 million (35% of revenue). The company generated $56 million cash from operations and ended the quarter with $353 million in cash. Management closed a $60 million private placement of senior secured notes due 2030 and filed DEA registration applications for 206 retail locations following medical marijuana rescheduling to Schedule III.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary in Belleview, Florida, with a grand opening celebration on May 8, 2026. The store at 5428 SE Abshier Boulevard offers walk-in and express pickup, home delivery statewide, and carries Trulieve in-house and partner brands.
Store hours: 9:00 a.m.–8:45 p.m. Monday–Saturday and 10:00 a.m.–8:00 p.m. Sundays. Veterans receive 20% off; first-time guests qualify for a 60% new-customer discount. More information is available at Trulieve.com and social channels.
Trulieve (OTCQX: TCNNF) filed applications with the U.S. Drug Enforcement Administration to register certain state‑licensed medical marijuana operations under the expedited pathway opened by rescheduling medical marijuana to Schedule III.
For applications submitted within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana is deemed approved unless the DEA notifies otherwise. Trulieve says it operates over 200 dispensaries serving only medical patients.
Trulieve (OTCQX: TCNNF) applauded the April 23, 2026 federal rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. The final order permits FDA‑approved and state licensed medical marijuana products to be reclassified, opens a DEA registration pathway for state operators, and notes Section 280E tax relief for Schedule III sales. The Department announced continued rulemaking with an expedited process and a planned hearing this summer.
Trulieve Cannabis Corp (OTCQX: TCNNF) will hold a conference call on May 7, 2026 at 8:30 AM ET to discuss first quarter 2026 financial and operating results. CEO Kim Rivers and CFO Jan Reese will participate. Dial-in and webcast access are provided for investors and analysts.
Live audio webcast and archived replay will be available at the company's investor events page.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary, Trulieve Ox Bottom, in Tallahassee on April 20, 2026. The location at 5138 Thomasville Road offers walk-in and express pickup, weekend hours, and a grand opening with specials, discounts, and partner giveaways.
The store will stock Trulieve in-house brands and partner brands, and Trulieve Florida services include home delivery, online ordering, and a 20% veterans discount plus a 60% new-customer discount.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary in Boca Raton, Florida, with a grand opening celebration on April 24, 2026.
The Glades Road store at 9293 Glades Road will offer walk-in and express pickup, home delivery statewide, extended hours, in-house brands, partner brands, veteran and first-time customer discounts.
Trulieve (OTCQX: TCNNF) opened a new medical cannabis dispensary in Lutz, Florida on April 11, 2026, with a grand opening celebration set for April 24, 2026.
The store at 24408 SR-54 offers walk-in and express pickup, extended hours, in-house and partner brands, home delivery, online ordering, a 20% veterans discount, and a 60% first-time guest discount in Florida.
Trulieve (OTCQX: TCNNF) announced that CEO Kim Rivers established an automatic securities disposition plan effective March 17, 2026. Sales may begin June 17, 2026 and continue until 2.5 million subordinate voting shares are sold, subject to daily volume limits, independent broker execution, and applicable U.S. and Canadian rules.
The ASDP is authorized by the compensation committee, restricts executive discretion, and will be reported under securities laws with filings accessible on SEDI and SEC systems.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary in DeLand, Florida with a grand opening on March 20, 2026. The store at 1329 North Woodland Boulevard offers walk-in and express pickup, weekday and weekend hours, and carries Trulieve and partner brands.
Services include home delivery, online ordering, veteran discounts (20% with military ID) and a 60% first-time guest discount at Florida locations. Hours: Mon–Sat 9:00 a.m.–8:45 p.m.; Sun 10:00 a.m.–8:00 p.m.